TRANXENE CAP 7.5MG CAPSULE
Country: Canada
Language: English
Source: Health Canada
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CLORAZEPATE DIPOTASSIUM
Available from:
ABBOTT LABORATORIES, LIMITED
ATC code:
N05BA05
INN (International Name):
CLORAZEPATE POTASSIUM
Dosage:
7.5MG
Pharmaceutical form:
CAPSULE
Composition:
CLORAZEPATE DIPOTASSIUM 7.5MG
Administration route:
ORAL
Units in package:
100
Prescription type:
Targeted (CDSA IV)
Therapeutic area:
BENZODIAZEPINES
Product summary:
Active ingredient group (AIG) number: 0108895002; AHFS:
Authorization status:
CANCELLED POST MARKET
Authorization date:
2003-08-01
